Table 2.
Level of COVID-19 vaccine acceptance by study area and sample size.
| Variables | Characteristics | Included studies | Sample size | Prevalence (95% CI) |
|---|---|---|---|---|
| Area | Addis Ababa | 4 | 1865 | 51.8% (33.3%–69.8%) |
| Amhara | 5 | 2106 | 54.2% (39.4%–68.3%) | |
| Southern | 5 | 2350 | 57.0% (44.4%–68.7%) | |
| Other (online/telephone) | 4 | 4552 | 68.7% (34.1%–90.3%) | |
|
| ||||
| Sample size | <400 | 2 | 697 | 63.5% (59.8%–67.0%) |
| 400–800 | 13 | 6814 | 55.2% (46.7%–63.4%) | |
| >800 | 3 | 3362 | 74.0% (23.5%–96.4%) | |